Endocrinology

The survey estimates from the National Center for Health Statistics report that more people are vaccinating for flu and testing for HIV.

Pregnant women with polycystic ovary syndrome taking metformin were 5% less likely to experience a miscarriage or preterm birth compared to those on placebo.

The GLP-1 receptor agonist is a similar, longer-acting formula to that of liraglutide, another successful therapy from Novo Nordisk that was recently approved for its second indication of lowering cardiovascular risk.

Adults with obesity treated with semaglutide 0.4 mg lost up to 13.8% of body weight after 52 weeks, significantly more weight than those treated with placebo who lost 2.3%.

The device will offer real-time tracking and alerts for glucose level high and low events, as well as telemedicine capabilities.

A joint statement from the Endocrine Society, the ADA, the AACE, and the AADE expressed strong disagreement with the ACP’s new guidelines, which raised goal A1C levels to between 7% and 8% for patients with T2D.

The therapies come on the tail of Amgen's failed attempt to receive a 6-month exclusivity extension for Sensipar.

The updated guidelines state that patients should be treated to achieve A1C levels between 7% and 8%.

A new classification of diabetes may provide information about underlying disease mechanisms and ultimately guide the choice of therapy.

Carb counting, bar-code recognition, log-book, exercise tracker, insulin calculator -- and more, all in each one of these 5 apps.

Medtronic had both its Guardian Sensor 3 CGM system and it's Resolute Onyx 2.0 mm drug-eluting stent approved by the FDA.

A rare genetic condition has been linked to the development of both diabetes and insulinomas in a single family.

Higher rates of stillbirths, the need for emergency Caesarean sections, and infant mortality have all been associated with both type 1 and type 2 diabetes

Findings indicated that Macrilen stimulated the pituitary gland to produce the growth hormone more effectively than the ITT.

OZEMPIC, a GLP-1 receptor agonist, was tested in 2-year cardiovascular outcome trials.

Reddit's Ask Me Anything forums have proven to give physicians a chance to connect with and educate thousands of people at once.

FDA sends response letter for deficiencies found in Antares Pharma’s QuickShot Testosterone auto injector.

The Certified Nurse Practicioner from the Henry Ford Medical Center also weighs in the best advice to avoid cardiovascular disease.

The drug, produced by Sanofi, was granted approval based on the physiochemical, non-clinical, and clinical similarity to another, already approved insulin lispro injection.

In just 9 days of limited fructose consumption, both liver fat concentration and de novo lipogensis decreased.

What's new in research on bisphosphonates, body-fat measurement, prebiotics, and insulin dosing? Find out with our quiz.

Sulforaphane has been found to lower glucose production and improve control in T2D patients.